The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations

Journal of Clinical Psychiatry

Volumn 73, Issue 7, 2012, Pages 967-976

  Sung, Sharon C ^a   Haley, Charlotte L ^a   Wisniewski, Stephen R ^b   Fava, Maurizio ^c   Nierenberg, Andrew A ^c   Warden, Diane ^d   Morris, David W ^d   Kurian, Benji T ^d   Trivedi, Madhukar H ^d   Rush, A John ^a  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; MIRTAZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SHORT COURSE THERAPY; SINGLE BLIND PROCEDURE; SOCIAL STATUS; UNSPECIFIED SIDE EFFECT;

EID: 84864414699     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07043     Document Type: Article

References (31)

1. Kessler RC, Berglund P, Demler O, et al; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105. doi:10.101/jama.289.23.3095 PubMed
2. Gilmer WS, Trivedi MH, Rush AJ, et al. Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr Scand. 2005;112(6):425-433. doi:10.1/j.160-047.205.063.x PubMed
3. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992;49(10):809-816. doi:10.101/archpsyc.192.018201053010 PubMed
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
5. Angst J, Gamma A, Rössler W, et al. Long-term depression versus episodic major depression: results from the prospective Zurich study of a community sample. J Affect Disord. 2009;115(1-2):112-121. doi:10.1016/j.jad.208. 09.023 PubMed
6. Blanco C, Okuda M, Markowitz JC, et al. The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2010;71(12):1645-1656. doi:10.408/JCP.09m0563gry PubMed
7. Gilmer WS, Gollan JK, Wisniewski SR, et al. Does the duration of index episode affect the treatment outcome of major depressive disorder? a STAR*D report. J Clin Psychiatry. 2008;69(8):1246-1256. doi:10.408/JCP.v69n0807 PubMed
8. Hölzel L, Härter M, Reese C, et al. Risk factors for chronic depression: a systematic review [published online ahead of print May 21, 2010]. J Affect Disord. 2011;129(1-3):1-13. doi:10.1016/j.jad.2010.03.025 PubMed
9. Klein DN, Shankman SA, Lewinsohn PM, et al. Family study of chronic depression in a community sample of young adults. Am J Psychiatry. 2004;161(4):646-653. doi:10.176/api.ajp.161.4.646 PubMed
10. Satyanarayana S, Enns MW, Cox BJ, et al. Prevalence and correlates of chronic depression in the Canadian Community Health Survey: Mental Health and Well-Being. Can J Psychiatry. 2009;54(6):389-398. PubMed
11. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. doi:10.176/api.ajp.163.1.28 PubMed
12. Kocsis JH, Gelenberg AJ, Rothbaum BO, et al; REVAMP Investigators. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry. 2009;66(11):1178-1188. doi:10.101/archgenpsychiatry.209.14 PubMed
13. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342(20):1462-1470. doi:10.1056/NEJM2051834201 PubMed
14. Blier P, Ward HE, Tremblay P, et al. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry. 2010;167(3):281-288. doi:10.176/api.ajp.209.09020186 PubMed
15. Rush AJ, Trivedi MH, Stewart JW, et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry. 2011;168(7):689-701. doi:10.176/api.ajp.201. 101645 PubMed
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry.
17. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001;58(8):787-794. doi:10.101/archpsyc.58.8.787 PubMed
18. Zimmerman M, Mattia JI. The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Compr Psychiatry. 2001;42(3):175-189. doi:10.1053/comp.201.23126 PubMed
19. Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156-163. doi:10.102/art.1093 PubMed
20. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. PubMed
21. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34(1):73-82. doi:10.1017/ S032917030107 PubMed
22. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008;165(3):342-351. doi:10.176/api.ajp.207.061868 PubMed
23. Trivedi MH, Wisniewski SR, Morris DW, et al. Concise Health Risk Tracking (CHRT) scale: a brief self-report and clinician-rating of suicidal risk. J Clin Psychiatry. 2011;72(6):765-774. PubMed
24. Altman EG, Hedeker D, Peterson JL, et al. The Altman Self-Rating Mania Scale. Biol Psychiatry. 1997;42(10):948-955. doi:10.1016/S06-323(96)0548-3 PubMed
25. Mundt JC, Marks IM, Shear MK, et al. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180(5):461-464. doi:10.192/bjp.180.5.461 PubMed
26. Frisch MB, Clark MP, Rouse SV, et al. Predictive and treatment validity of life satisfaction and the Quality of Life Inventory. Assessment. 2005;12(1):66-78. doi:10.17/10731910426806 PubMed
27. Wisniewski SR, Rush AJ, Balasubramani GK, et al; for the STAR*D Investigators. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006;12(2):71-79. doi:10.1097/0131746- 206030-02 PubMed
28. Levine J, Schooler NR. General versus specific inquiry with SAFTEE [letter]. J Clin Psychopharmacol. 1992;12(6):448. doi:10.1097/04714-192120-017 PubMed
29. Arnow BA, Constantino MJ. Effectiveness of psychotherapy and combination treatment for chronic depression. J Clin Psychol. 2003;59(8):893-905. doi:10.102/jclp.10181 PubMed
30. Kocsis JH, Rush AJ, Markowitz JC, et al. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Psychopharmacol Bull. 2003;37(4):73-87. PubMed
31. Stulz N, Thase ME, Klein DN, et al. Differential effects of treatments for chronic depression: a latent growth model reanalysis. J Consult Clin Psychol. 2010;78(3):409-419. doi:10.1037/a019267 PubMed